Biosafety testing is a critical component in the development and approval of pharmaceuticals and biological products. This testing ensures that any new product released into the market is safe for human use and does not pose any health risks. It involves a series of rigorous assessments, including the evaluation of potential contaminants, pathogens, and toxins that might be present in the product. The process also includes assessing the safety of genetically modified organisms (GMOs) and other advanced biotechnological products. By adhering to strict regulatory guidelines, companies can prevent adverse reactions and ensure that their products provide their intended benefits without compromising user safety. Conducting thorough biosafety testing is not just a regulatory requirement but also a vital step in maintaining public health and trust in medical innovations.